Dear Friend,
Emily Dumler was facing a type of non-Hodgkin lymphoma. She’d had her spleen removed, received numerous drugs to increase platelet counts, endured more than a half-dozen courses of chemotherapy and underwent a stem cell transplant.
But she still had cancer.
“It was terrifying... I had no good options left,” she remembers.
But doctors here at The University of Texas MD Anderson Cancer Center were launching a clinical trial of chimeric antigen receptor (CAR) T-cell therapy, which re-engineers the body’s T cells so they can recognize, attack and kill cancer.
Since May is National Cancer Research Month, I’m asking you to please join us in Making Cancer History®. Your gift to MD Anderson will help our world-class researchers find new treatments and cures to #endcancer.
Within one month of treatment, Emily’s cancer was gone. And the trial therapy that saved her life has been approved for all patients with lymphoma.
Please give as generously as you can to help support leading-edge cancer research and give more people like Emily, and their families, hope.
Thanks in advance,
Maria Gelormini Senior Associate Vice President for Development Services
P.S. When you donate, you can designate your gift in honor or memory of someone you love. There’s no more meaningful way to pay tribute.
|